Protease‐modified erythrocytes: CD55 and CD59 deficient PNH‐like cells
- 1 February 1995
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 73 (1) , 66-72
- https://doi.org/10.1038/icb.1995.11
Abstract
The increased susceptibility to homologous complement in paroxysmal nocturnal haemoglobinuria (PNH) is known to be associated with the deficiency of the membrane complement inhibitors CD59 and CD55. Proteases have been used in this study to modify normal human RBC to complement sensitive PNH-like cells. To investigate the protective role of CD59 and CD55, the relationship between the content of CD59 and CD55 and the complement susceptibility of the PNH-like cells has been determined. The differential resistance of the enzyme-treated RBC to complement-mediated injury was measured by acidified serum lysis. Pronase-treated erythrocytes lacked both CD59 and CD55 and were very susceptible to complement-mediated lysis. Papain treatment of RBC reduced the CD55 content but did not affect CD59 and induced slight susceptibility to complement-mediated lysis. Trypsin treatment of RBC destroyed 80% of CD59, had little effect on CD55 (unless incubation was extended) and slightly increased susceptibility to lysis. Thus, partial CD55 and CD59 activity was sufficient to protect cells from complement-mediated lysis. In the reactive lysis assay, anti-CD55 and anti-CD59 induced haemolysis, anti-CD59 having the more pronounced effect. Lysis was enhanced when RBC were treated by both antibodies simultaneously.Keywords
This publication has 29 references indexed in Scilit:
- The molecular basis for paroxysmal nocturnal hemoglobinuriaTransfusion, 1993
- Test for Ability of Decay-Accelerating Factor (DAF, CD55) and CD59 to Alleviate Complement-Mediated Damage of Xeno-ErythrocytesScandinavian Journal of Immunology, 1993
- The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor BiosynthesisScience, 1993
- The CD59 antigen ‐ a multifunctional moleculeTissue Antigens, 1992
- The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysisBritish Journal of Haematology, 1991
- Proteolytic elimination of decay-accelerating factor (DAF): Lytic abnormality coincides with removal of DAF in papain-treated human erythrocytesMolecular Immunology, 1990
- Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- Studies on the sensitivity to complement‐mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor)British Journal of Haematology, 1989
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Inactivation of Kell blood group antigens by 2‐aminoethylisothiouronium bromideBritish Journal of Haematology, 1982